Minneapolis, MN · Founded 2013 · Privately Held (backing)
Developer of molecular imaging probes designed for the diagnosis and removal of cancer cells. Vergent Bioscience is based in Minneapolis, MN and was founded in 2013. It was valued at $75 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $56.4 million across 5 recorded rounds; the latest was an $18.7 million early-stage round in Oct 2025.
PMV mark · valuation
$75.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$56.4M
Last round
Early Stage VC
Oct 2025
Cap table — not yet on record
Vergent Bioscience's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vergent Bioscience with a free account
·Watch Vergent Bioscience: the Monday email on marks, rounds and moves
Where does Vergent Bioscience's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Vergent Bioscience's 5 recorded funding rounds.
